secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kura Oncology, Inc. (KURA)
CIK:        0001422143
Form:       8-K
Filed at:   2023-01-13T23:59:59+00:00
Accession:  0001193125-23-008358
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Kura Oncology CCO Kirsten Flowers resigns; separation agreement provides 6 months salary + 2022 bonus
--------------------------------------------------------------------------------

- Kirsten Flowers resigns as Chief Commercial Officer effective Jan 27, 2023.
- Separation agreement provides 6 months base salary and 2022 annual cash bonus (discretionary).
- Flowers agrees to a 6-month non-compete period following separation.
- No successor named; search for replacement is ongoing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1422143/000119312523008358/0001193125-23-008358-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1422143/000119312523008358/d381827d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-008358

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer